Lupus Research Alliance Welcomes New Executive VP of Lupus Therapeutics: A Step Forward in the Battle Against Lupus

The Lupus Research Alliance (LRA) is delighted to announce the appointment of Stacie J. Bell, PhD as Executive Vice President to head up Lupus Therapeutics, the organization’s clinical research arm. Dr. Bell brings to the table an impressive background in medical research, offering the perfect blend of experience and knowledge to help LRA continue its mission of finding a cure for lupus.

Dr. Bell brings an impressive wealth of experience to Lupus Therapeutics, having worked in biopharmaceutical and nonprofit settings for over two and a half decades, contributing to discovery research, clinical development, and patient engagement. With this extensive background, he is poised to make a major impact on the organization.

Recently, Dr. Nita Mosby Tyler has taken on a new challenge – tackling global nutrition issues head on. With her leadership as CEO and President of the Global Nutrition Project, a nonprofit organization, she is aiming to revolutionize the health of people and the planet by utilizing cutting-edge technologies and forming collaborations with various entities to leverage big data. Her mission is to empower humanity to create positive change.

Dr. Bell made a remarkable impact on advancing research and medical affairs when she served as Chief Scientific and Medical Officer for the National Psoriasis Foundation. During her tenure, she established the organization’s first clinical study, strengthened partnerships to better serve the community, and worked with health policy makers. She also joined the working group for the Accelerated Medicine Partnership program for its second phase, AMP-AIM. This federal program, which the Lupus Research Alliance has been a part of since the beginning, seeks to accelerate the understanding of disease mechanisms, treatment innovation, and personalized medicine with the help of stakeholders from industry, academics, and government agencies.

We are delighted to welcome Dr. Bell to the Lupus Research Alliance! With her impressive background in academic, pharmaceutical, and non-profit settings, she is the perfect fit to help Lupus Therapeutics continue to grow and reach its goals. Dr. Bell’s expertise in science and technology, combined with her passion for supporting the lupus patient community, will make a powerful contribution towards our mission of meeting urgent needs and ultimately eradicating lupus.

I am thrilled to join the Lupus Therapeutics team and collaborate with the lupus community to create a brighter future for those living with this unpredictable and potentially debilitating disease. My experience in immunology and rheumatology has allowed me to make strides in improving patient care and expanding treatment options, and I am eager to continue this work and make an even greater impact. Together, we can increase patient engagement and accelerate clinical research to bring hope to those affected by lupus.

Dr. Bell has had a long and successful career in the field of biochemistry, beginning as a Graduate Research Associate at Vanderbilt University School of Medicine. During her time there, she earned her PhD in Biochemistry, while also graduating summa cum laude with a BS in Chemistry from University of North Dakota. Her dedication to the field of biochemistry has enabled her to become an expert in her field.

About Lupus

Lupus is an unpredictable and often debilitating autoimmune disorder that affects millions of people around the world. While people of all genders, ages, and ethnic backgrounds can develop lupus, it is most often seen in women during their childbearing years, ages 15 to 45. African Americans, Latinx, Asians, and Native Americans are two to three times more likely to suffer from lupus than Caucasians. Lupus is an unpredictable disease, as the body’s own immune system can attack any organ or tissue, including the kidneys, brain, heart, lungs, blood, skin, and joints. It can be a challenging and difficult condition to manage, but with the right care and support, people with lupus can lead healthy and fulfilling lives.

About Lupus Therapeutics

Lupus Therapeutics is on a mission to accelerate the development of life-changing treatments and diagnostics for lupus patients. Through our unprecedented Lupus Clinical Investigators Network (LuCIN), we collaborate with biotechnology and pharmaceutical partners to ensure that the patient voice is at the heart of our clinical research process. Our network of world-class experts throughout North America is committed to bringing rapid and meaningful progress in the treatment of lupus. Visit to learn more about our mission and join the fight against lupus!

About the Lupus Research Alliance

The Lupus Research Alliance (LRA) is on a mission to transform treatment and ultimately find a cure for lupus—the world’s leading non-governmental, non-profit funder of lupus research. Our board of directors funds all administrative and fundraising costs so that 100 percent of donations can go towards innovative lupus research programs, creating diverse scientific talent and driving us closer to better diagnostics and improved treatments. Let’s join forces to make lupus a thing of the past.

Leave a Comment